By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Promedior 

5 Great Valley Parkway
Suite 300
Malvern  Pennsylvania  19355  U.S.A.
Phone: 610-560-1435 Fax: 610-560-1436


SEARCH JOBS








Company News
Promedior Presents Positive Phase 2 Data For PRM-151 In Myelofibrosis At American Society of Hematology Annual Meeting 12/9/2014 9:46:55 AM
Promedior Receives Fast Track Designation For PRM-151 For The Treatment Of Myelofibrosis 11/3/2014 10:46:50 AM
Promedior Announces Presentation Of Retrospective Quantitative Imaging Analysis Of Phase 1b Data In Idiopathic Pulmonary Fibrosis 9/22/2014 9:16:57 AM
Promedior Receives U.S. Orphan Drug Designation For PRM-151 For The Treatment Of Myelofibrosis 9/2/2014 11:28:09 AM
Promedior Receives U.S. Orphan Drug Designation For PRM-151 For Fhe Treatment Of Myelofibrosis 9/2/2014 10:41:41 AM
Promedior Announces Presentation Of Interim Phase 2 Data On PRM-151 In Myelofibrosis At The Upcoming Congress Of European Hematology Association 6/5/2014 7:41:29 AM
Tiny Promedior To Present Positive Phase 2 Myelofibrosis Data Next Week 5/30/2014 6:42:10 AM
Promedior Announces Presentation Of Interim Phase 2 Data On PRM-151 In Myelofibrosis At American Society of Clinical Oncology 5/15/2014 9:14:04 AM
Promedior Attains Patient Enrollment Milestone In Phase 2 Clinical Study Of PRM-151 In Myelofibrosis 1/8/2014 9:04:09 AM
Promedior Initiates Phase 2 Clinical Study of PRM-151 in Myelofibrosis 10/9/2013 9:54:21 AM
12345
//-->